Clinical Trial

A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Name: A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — clinical trial record (NCT07139535)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The goal for this study is to evaluate the efficacy and safety of RAY1225 versus placebo in participants with type 2 diabetes not under control with diet and exercise alone.

Trial Details

NCT Number	NCT07139535
Lead Sponsor	Guangdong Raynovent Biotech Co., Ltd
Conditions	T2DM
Enrollment	350 participants
Start Date	2025-08-31
Primary Completion	2026-12-01 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-24